KOPS - Das Institutionelle Repositorium der Universität Konstanz

Protein expression profile of HT-29 human colon cancer cells after treatment with a cytotoxic daunorubicin-GnRH-III derivative bioconjugate

Protein expression profile of HT-29 human colon cancer cells after treatment with a cytotoxic daunorubicin-GnRH-III derivative bioconjugate

Zitieren

Dateien zu dieser Ressource

Prüfsumme: MD5:e542306cd206bf61dd157d8e057b4803

SCHREIER, Verena Natalie, Lilla PETHŐ, Erika ORBÁN, Andreas MARQUARDT, Brindusa Alina PETRE, Gábor MEZŐ, Marilena MANEA, 2014. Protein expression profile of HT-29 human colon cancer cells after treatment with a cytotoxic daunorubicin-GnRH-III derivative bioconjugate. In: PLoS ONE. 9(4), e94041. eISSN 1932-6203. Available under: doi: 10.1371/journal.pone.0094041

@article{Schreier2014Prote-27607, title={Protein expression profile of HT-29 human colon cancer cells after treatment with a cytotoxic daunorubicin-GnRH-III derivative bioconjugate}, year={2014}, doi={10.1371/journal.pone.0094041}, number={4}, volume={9}, journal={PLoS ONE}, author={Schreier, Verena Natalie and Pethő, Lilla and Orbán, Erika and Marquardt, Andreas and Petre, Brindusa Alina and Mező, Gábor and Manea, Marilena}, note={Article Number: e94041} }

<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/27607"> <dc:contributor>Marquardt, Andreas</dc:contributor> <dc:creator>Manea, Marilena</dc:creator> <dc:contributor>Pethő, Lilla</dc:contributor> <dc:language>eng</dc:language> <dcterms:title>Protein expression profile of HT-29 human colon cancer cells after treatment with a cytotoxic daunorubicin-GnRH-III derivative bioconjugate</dcterms:title> <dc:creator>Marquardt, Andreas</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-04-15T09:25:40Z</dcterms:available> <dc:creator>Pethő, Lilla</dc:creator> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/52"/> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/27607/2/Schreier_276071.pdf"/> <dc:creator>Schreier, Verena Natalie</dc:creator> <dc:contributor>Orbán, Erika</dc:contributor> <dcterms:bibliographicCitation>PLoS ONE ; 9 (2014), 4. - e94041</dcterms:bibliographicCitation> <dcterms:issued>2014</dcterms:issued> <dcterms:abstract xml:lang="eng">Targeted delivery of chemotherapeutic agents is a new approach for the treatment of cancer, which provides increased selectivity and decreased systemic toxicity. We have recently developed a promising drug delivery system, in which the anticancer drug daunorubicin (Dau) was attached via oxime bond to a gonadotropin-releasing hormone-III (GnRH-III) derivative used as a targeting moiety (Glp-His-Trp-Lys(Ac)-His-Asp-Trp-Lys(Dau = Aoa)-Pro-Gly-NH2; Glp = pyroglutamic acid, Ac = acetyl; Aoa = aminooxyacetyl). This bioconjugate exerted in vitro cytostatic/cytotoxic effect on human breast, prostate and colon cancer cells, as well as significant in vivo tumor growth inhibitory effect on colon carcinoma bearing mice. In our previous studies, H-Lys(Dau = Aoa)-OH was identified as the smallest metabolite produced in the presence of rat liver lysosomal homogenate, which was able to bind to DNA in vitro. To get a deeper insight into the mechanism of action of the bioconjugate, changes in the protein expression profile of HT-29 human colon cancer cells after treatment with the bioconjugate or free daunorubicin were investigated by mass spectrometry-based proteomics. Our results indicate that several metabolism-related proteins, molecular chaperons and proteins involved in signaling are differently expressed after targeted chemotherapeutic treatment, leading to the conclusion that the bioconjugate exerts its cytotoxic action by interfering with multiple intracellular processes.</dcterms:abstract> <dc:creator>Mező, Gábor</dc:creator> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/52"/> <dc:contributor>Petre, Brindusa Alina</dc:contributor> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dc:creator>Orbán, Erika</dc:creator> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-04-15T09:25:40Z</dc:date> <dcterms:rights rdf:resource="http://nbn-resolving.org/urn:nbn:de:bsz:352-20140905103605204-4002607-1"/> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/29"/> <dc:creator>Petre, Brindusa Alina</dc:creator> <dc:contributor>Manea, Marilena</dc:contributor> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/27607/2/Schreier_276071.pdf"/> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:contributor>Schreier, Verena Natalie</dc:contributor> <dc:contributor>Mező, Gábor</dc:contributor> <dc:rights>deposit-license</dc:rights> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/29"/> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/27607"/> </rdf:Description> </rdf:RDF>

Dateiabrufe seit 01.10.2014 (Informationen über die Zugriffsstatistik)

Schreier_276071.pdf 226

Das Dokument erscheint in:

KOPS Suche


Stöbern

Mein Benutzerkonto